<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02140567</url>
  </required_header>
  <id_info>
    <org_study_id>Syncope Prediction Study</org_study_id>
    <secondary_id>SPS</secondary_id>
    <nct_id>NCT02140567</nct_id>
  </id_info>
  <brief_title>Syncope Prediction Study</brief_title>
  <acronym>SPS</acronym>
  <official_title>Syncope Prediction Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic BRC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic BRC</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to perform a prospective evaluation of the vasovagal syncope
      prediction algorithm, called Tilt Test Analyzer, during head up tilt testing tests in one
      center in the United Kingdom.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Vasovagal syncope (VVS) is a form of neurally-mediated reflex syncope, which is marked by a
      sudden fall in blood pressure with an associated fall in heart rate often resulting in
      syncope, head-up tilt (HUT) testing is commonly used to bring information about VVS using ECG
      and blood pressure monitoring with medical observation.

      We developed an algorithm, called Tilt Test Analyzer, to predict VVS during HUT based on the
      simultaneous analysis of heart rate (RR interval), systolic blood pressure (SBP) and an
      indicator of autonomic modulation represented by heart rate and blood pressure variability
      (HRV and BPV).

      The primary objective of this study is to evaluate the VVS prediction algorithm in a
      prospective cohort of patients in the tilt laboratory The primary endpoint is the VVS
      prediction algorithm performance by means of measuring the sensitivity and specificity
      values.

      The study is designed to test if the prospective analysis of tilt-test patients can reproduce
      the results previously obtained in the published retrospective analysis on 1155 patients with
      a similar clinically relevant sensitivity and specificity.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2014</start_date>
  <completion_date type="Actual">November 2016</completion_date>
  <primary_completion_date type="Actual">October 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Sensitivity of the Syncope Prediction Algorithm</measure>
    <time_frame>Tilt Test with average duration of 1 hour</time_frame>
    <description>Number of tilt-positive participants predicted in the right way by the syncope prediction algorithm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Specificity of the Syncope Prediction Algorithm</measure>
    <time_frame>Tilt Test with average duration of 1 hour</time_frame>
    <description>Number of tilt-negative participants identified as negative by the syncope prediction algorithm</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">140</enrollment>
  <condition>Vasovagal Syncope</condition>
  <arm_group>
    <arm_group_label>Syncope Prediction</arm_group_label>
    <description>All enrolled patients that performed the tilt table test</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Vasovagal syncope patients
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients referred to the center with vasovagal syncope for tilt testing.

          -  The patient is willing and able to cooperate with the study procedures.

          -  The subject or legal guardian is able to provide written informed consent

        Exclusion Criteria:

          -  Patients under 18 years or over 90 years old.

          -  Women who are currently pregnant or have a positive pregnancy test.

          -  Patients who had a prior tilt test.

          -  Patients enrolled in another device or drug study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>P Boon Lim, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hammersmith Hospital, Imperial College Healthcare NHS Trust</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hammersmith Hospital, Imperial College Healthcare NHS Trust</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>April 30, 2014</study_first_submitted>
  <study_first_submitted_qc>May 14, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 16, 2014</study_first_posted>
  <results_first_submitted>December 1, 2017</results_first_submitted>
  <results_first_submitted_qc>December 1, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">August 27, 2018</results_first_posted>
  <last_update_submitted>February 22, 2019</last_update_submitted>
  <last_update_submitted_qc>February 22, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syncope</mesh_term>
    <mesh_term>Syncope, Vasovagal</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Syncope Prediction Study</title>
          <description>All enrolled participants who performed a tilt test.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="140"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="134"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Problems with recording equipment</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Participants included in efficacy analysis</population>
      <group_list>
        <group group_id="B1">
          <title>Syncope Prediction</title>
          <description>Enrolled participants who performed tilt test and were included in efficacy analysis</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="134"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37.2" spread="15.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="92"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Sensitivity of the Syncope Prediction Algorithm</title>
        <description>Number of tilt-positive participants predicted in the right way by the syncope prediction algorithm</description>
        <time_frame>Tilt Test with average duration of 1 hour</time_frame>
        <population>Number of participants with positive tilt-test</population>
        <group_list>
          <group group_id="O1">
            <title>Syncope Prediction (Sensitivity)</title>
            <description>Tilt-positive participants included in the efficacy analysis</description>
          </group>
        </group_list>
        <measure>
          <title>Sensitivity of the Syncope Prediction Algorithm</title>
          <description>Number of tilt-positive participants predicted in the right way by the syncope prediction algorithm</description>
          <population>Number of participants with positive tilt-test</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="83"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>True positive</title>
                  <measurement_list>
                    <measurement group_id="O1" value="81"/>
                  </measurement_list>
                </category>
                <category>
                  <title>False negative</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Specificity of the Syncope Prediction Algorithm</title>
        <description>Number of tilt-negative participants identified as negative by the syncope prediction algorithm</description>
        <time_frame>Tilt Test with average duration of 1 hour</time_frame>
        <population>Number of participants with negative tilt-test</population>
        <group_list>
          <group group_id="O1">
            <title>Syncope Prediction (Specificity)</title>
            <description>Tilt-negative participants included in the efficacy analysis</description>
          </group>
        </group_list>
        <measure>
          <title>Specificity of the Syncope Prediction Algorithm</title>
          <description>Number of tilt-negative participants identified as negative by the syncope prediction algorithm</description>
          <population>Number of participants with negative tilt-test</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>True negative</title>
                  <measurement_list>
                    <measurement group_id="O1" value="45"/>
                  </measurement_list>
                </category>
                <category>
                  <title>False positive</title>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 hour</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Syncope Prediction</title>
          <description>Enrolled participants who performed the tilt test</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="140"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="140"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="140"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Phang Boon Lim</name_or_title>
      <organization>Imperial College Healthcare NHS Trust in London, United Kingdom</organization>
      <phone>+44 ext (0)20 3313</phone>
      <email>p.b.lim@imperial.ac.uk</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

